Back

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study

26 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Atrial fibrillation - Stroke prevention - General Oral Anticoagulation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Xiaoyan Li

Princeton (United States of America)

8 More presentations in this session

Presentation thumbnail
Associate Professor E. Grove (Aarhus, DK)
Abstract Slides
Presentation thumbnail
Ms K. Pieper (London, GB)
Abstract Slides
Presentation thumbnail
Professor G. Lip (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Professor U. Zeymer (Ludwigshafen, DE)
Abstract
Presentation thumbnail
Professor A. Bisson (Tours, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Atrial fibrillation - Stroke prevention - General

The Event

Event poster

ESC Congress 2018

26 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Comparative effectiveness and safety of non-VKA oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with differential treatment duration: an ARISTOPHANES study analysis
2 September 2019
thumbnail
Congress Session
Stroke and bleeding risk in atrial fibrillation: walking the tight rope
25 August 2023
thumbnail
Congress Presentation
Plasma levels of direct oral anticoagulants in non-valvular atrial fibrillation patients at the time of acute cardioembolic or bleeding events
28 August 2023
thumbnail
Congress Presentation
Reduced dose, but not reduced risk: rates of inappropriate apixaban dose reduction and stroke and bleeding incidence
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources